BACKGROUND: Hepatocellular carcinoma [HCC] is the second leading cause ofcancer death worldwide. For HCC diagnosed at early stages, curative treatmentby liver resection [LR] achieves a 5-year overall survival [OS] of 50–70%. HCCsdeveloping in non-cirrhotic liver or as a solitary tumor in compensated cirrhosisare ideal targets for LR. However, optimal pre-operative assessment of HCCpatients and prediction of their outcomes are challenging. ...
إقراء المزيد